Effect of simultaneous administration of clofibrate with diethylnitrosamine on hepatic tumorigenesis in the rat
- 30 April 1983
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 19 (1) , 99-105
- https://doi.org/10.1016/0304-3835(83)90142-8
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effects of various concentrations of ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) on diethylnitrosamine-induced hepatic tumorigenesis in the ratCarcinogenesis: Integrative Cancer Research, 1982
- Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2, 3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14, 643) in the semipurified dietCarcinogenesis: Integrative Cancer Research, 1981
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980
- Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in ratsBritish Journal of Cancer, 1979
- Malignant Tumors in Rats Fed Nafenopin, a Hepatic Peroxisome Proliferator 2JNCI Journal of the National Cancer Institute, 1977
- Modification of Diethylnitrosamine Liver Carcinogenesis With Phenobarbital but not With Immunosuppression2JNCI Journal of the National Cancer Institute, 1975
- Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolismJournal of Medicinal Chemistry, 1974
- Die Beeinflussung der Nitrosamincarcinogenese durch Phenobarbital und HalogenkohlenwasserstoffeZeitschrift für Krebsforschung und Klinische Onkologie, 1969
- EFFECT OF BARBITAL ON CARCINOGENIC ACTION AND METABOLISM OF 4-DIMETHYLAMINOAZOBENZENE1967